Immediate Impact

1 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

Evaluation of synergism in drug combinations and reference models for future orientations in oncology
2022 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2 intermediate papers

Works of Melcior Riera being referenced

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
2015
Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy
2008

Author Peers

Author Last Decade Papers Cites
Melcior Riera 476 347 24 188 14 573
Cristina Mussini 328 228 17 112 25 474
Miguel Goicoechea 456 280 14 180 17 558
Anders Sönnerborg 484 254 28 95 15 607
Mary Morrow 528 306 13 89 32 630
Sirinya Teeraananchai 386 218 5 189 26 522
Paola Germano 514 263 5 148 24 623
Annapaola Callegaro 486 423 6 113 23 574
Robert Grossberg 365 131 62 87 24 531
Anna Danise 374 287 6 102 24 492
Antonio Antela 493 390 14 137 19 632

All Works

Loading papers...

Rankless by CCL
2026